Merck KGaA Cash Flow Conversion Efficiency

Latest as of June 2026: 0.020x

Merck KGaA cash flow conversion efficiency. Based on the latest financial reports, Merck KGaA (MRK) has a cash flow conversion efficiency ratio of 0.020x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€605.00 Million ≈ $707.31 Million USD) by net assets (€30.29 Billion ≈ $35.41 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Merck KGaA (2002–2025)

Cash flow conversion efficiency of Merck KGaA from 2002 to 2025. This chart illustrates how Merck KGaA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Merck KGaA (MRK) share price today for real-time trading data and today's change.

Merck KGaA Cash Flow Conversion Ratio Explained

Merck KGaA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Merck KGaA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Merck KGaA ranked by their cash flow conversion efficiency. Also see how much is Merck KGaA worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Loews Corp NYSE:L	0.048x
AerCap Holdings NV NYSE:AER	0.079x
Amadeus IT Group S.A. MC:AMS	0.086x
Global Payments Inc NYSE:GPN	0.016x
CRRC Corp Ltd Class A SHG:601766	0.167x
Geely Automobile Holdings Limited F:GRUA	0.058x
Hindalco Industries Limited NSE:HINDALCO	0.060x
Zomato Limited NSE:ZOMATO	0.012x

Annual Cash Flow Conversion Efficiency for Merck KGaA (2002–2025)

The table below shows the annual cash flow conversion efficiency of Merck KGaA from 2002 to 2025. Review MRK free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€28.66 Billion ≈ $33.51 Billion	€3.93 Billion ≈ $4.60 Billion	0.137x	-10.29%
2024-12-31	€29.99 Billion ≈ $35.06 Billion	€4.59 Billion ≈ $5.36 Billion	0.153x	+8.13%
2023-12-31	€26.75 Billion ≈ $31.28 Billion	€3.78 Billion ≈ $4.42 Billion	0.141x	-13.64%
2022-12-31	€26.00 Billion ≈ $30.40 Billion	€4.26 Billion ≈ $4.98 Billion	0.164x	-24.02%
2021-12-31	€21.42 Billion ≈ $25.04 Billion	€4.62 Billion ≈ $5.40 Billion	0.216x	+5.49%
2020-12-31	€17.02 Billion ≈ $19.89 Billion	€3.48 Billion ≈ $4.06 Billion	0.204x	+28.15%
2019-12-31	€17.91 Billion ≈ $20.94 Billion	€2.86 Billion ≈ $3.34 Billion	0.159x	+23.82%
2018-12-31	€17.23 Billion ≈ $20.15 Billion	€2.22 Billion ≈ $2.59 Billion	0.129x	-32.82%
2017-12-31	€14.07 Billion ≈ $16.44 Billion	€2.70 Billion ≈ $3.15 Billion	0.192x	+6.95%
2016-12-31	€14.05 Billion ≈ $16.43 Billion	€2.52 Billion ≈ $2.94 Billion	0.179x	+4.95%
2015-12-31	€12.86 Billion ≈ $15.03 Billion	€2.20 Billion ≈ $2.57 Billion	0.171x	-25.52%
2014-12-31	€11.80 Billion ≈ $13.80 Billion	€2.71 Billion ≈ $3.16 Billion	0.229x	+14.03%
2013-12-31	€11.07 Billion ≈ $12.94 Billion	€2.23 Billion ≈ $2.60 Billion	0.201x	-15.30%
2012-12-31	€10.41 Billion ≈ $12.18 Billion	€2.47 Billion ≈ $2.89 Billion	0.237x	+95.95%
2011-12-31	€10.49 Billion ≈ $12.27 Billion	€1.27 Billion ≈ $1.49 Billion	0.121x	-29.51%
2010-12-31	€10.37 Billion ≈ $12.13 Billion	€1.78 Billion ≈ $2.08 Billion	0.172x	+19.24%
2009-12-31	€9.51 Billion ≈ $11.12 Billion	€1.37 Billion ≈ $1.60 Billion	0.144x	+35.42%
2008-12-31	€9.62 Billion ≈ $11.25 Billion	€1.02 Billion ≈ $1.20 Billion	0.106x	-24.10%
2007-12-31	€8.69 Billion ≈ $10.16 Billion	€1.22 Billion ≈ $1.42 Billion	0.140x	-34.22%
2006-12-31	€3.81 Billion ≈ $4.45 Billion	€811.70 Million ≈ $948.96 Million	0.213x	-3.11%
2005-12-31	€3.33 Billion ≈ $3.89 Billion	€732.50 Million ≈ $856.37 Million	0.220x	+11.57%
2004-12-31	€2.89 Billion ≈ $3.38 Billion	€570.90 Million ≈ $667.44 Million	0.197x	-38.07%
2003-12-31	€2.36 Billion ≈ $2.76 Billion	€752.40 Million ≈ $879.63 Million	0.318x	+55.07%
2002-12-31	€2.05 Billion ≈ $2.40 Billion	€421.70 Million ≈ $493.01 Million	0.205x	--

About Merck KGaA

XETRA:MRK Germany Drug Manufacturers - Specialty & Generic

Market Cap

$22.72 Billion

€19.43 Billion EUR

Market Cap Rank

#1137 Global

#262 in Germany

Share Price

€150.35

Change (1 day)

-0.07%

52-Week Range

€102.80 - €151.30

All Time High

€220.61